3 results
Approved WMORecruitment started
The aim of this research is to decrease the number of involved margins, resulting in less adjuvant therapy and less local recurrences.
Approved WMORecruitment started
The goal of this study is to investigate which treatment(-s) lead to the best outcome by using existing variation of practice.
Approved WMORecruitment started
In the RAINBO POLEmut-BLUE trial, omission of adjuvant therapy will be investigated in very low risk disease and de-escalation of treatment (observation or radiotherapy, but not chemoradiation) in low risk disease.